Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H.P. Acthar Gel in CNS Sarcoidosis
NCT02298491Phase 4Completed
- Sponsor
- University of Maryland, Baltimore
- Start
- May 2016
- Primary completion
- Nov 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of repository corticotropin injection in neurosarcoidosis, sponsored by University of Maryland, Baltimore. Started May 2016; status: completed.
02
Drugs
repository corticotropin injection
03
Conditions
neurosarcoidosis
Beyond the preview
Go deeper on NCT02298491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02298491.